Circular Genomics: Paul Sargeant

Circular Genomics, an Albuquerque, New Mexico-based company developing precision medicine and diagnostic tools based on circular RNA, has appointed Paul Sargeant as CEO. Sargeant has more than 25 years of life science industry leadership and management experience including clinical diagnostics assay, instrumentation platform, and software development; regulatory approvals; and commercial launch experience, according to Circular. Most recently, Sargeant was CEO of Rebus Biosystems, an Illumina Ventures-backed spatial biology company. He holds a PhD in physiology from the University of Cambridge.